Treating Blood Cancers

Kerry Cook, PA-C, New York Presbyterian/Columbia University Irving Medical Center, New York, NY Recorded on April 8, 2020 The uncertainty surrounding the COVID-19 pandemic is particularly worrisome to vulnerable populations, particularly cancer patients. How do oncology healthcare professionals care for their patients, each other, and themselves during this time? Join Dr. Miller as he speaks with...

Frederick R. Appelbaum, MD, Fred Hutchinson Cancer Research Center, Seattle, WA Recorded on February 4, 2020 In this special episode, Dr. Miller sits down with Dr. Frederick Appelbaum, Executive Vice President and Deputy Director, Fred Hutchinson Cancer Research Center, Professor, Division of Medical Oncology, at the University Of Washington School Of Medicine in Seattle, WA to discuss the history...

Edith P. Mitchell, MD, MACP, FCPP, Sydney Kimmel Cancer Center at Jefferson, Philadelphia, PA Recorded on January 15, 2020 Thirty-two thousand Americans are diagnosed with myeloma each year and 13,000 die of this disease. While the five-year survival has risen over the past 20 years, some groups of patients are being left behind. Today, African Americans are 2.6 times more likely to die of the dis...

Jacqueline Casillas, MD, David Geffen School of Medicine at UCLA, Los Angeles, CA Recorded on January 8, 2020 As overall survival rates for childhood cancers continue to rise, survivors face challenges related to the long-term and late effects of their diagnosis and treatment. In this episode, Jacqueline Casillas, MD, Director of the Pediatric, Adolescent and Young Adult Survivorship Program at UC...

Marybeth Medicke, MSN, RN, El Paso Community College, El Paso, TX Recorded on November 21, 2019 What is compassion fatigue? How does it differ from burnout? What behaviors do healthcare professionals with compassion fatigue exhibit? What can you do to stay engaged in your work? In this episode, Marybeth Medicke, MSN, RN, a registered nurse and faculty member at the El Paso Community College discus...

Anita Kumar, MD, Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ Recorded on November 11, 2019 What is mantle cell lymphoma (MCL)? How is it diagnosed? How does it differ from chronic lymphocytic leukemia? In this episode, Dr. Anita Kumar of Memorial Sloan Kettering Cancer Center breaks down the biology of the disease, addresses new and emerging treatment options, and discusses approache...

Susan McCall, MSN, ANP-BC, AOCNP®, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on September 18, 2019 How do healthcare professionals communicate with patients about the issues related to living with a chronic disease? In this episode, Susan McCall, ANP-BC, AOCNP®, a nurse practitioner at Memorial Sloan Kettering Cancer Center in New York, discusses her role in educating patients...

Elizabeth A. Weber, BSN, RN, Heather DiFilippo, MSN, CRNP and Erin Medoff, RN, MSN, APRN Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019 In this episode, we are joined by three nurses to discuss their important and varied roles in treating patients with CAR T-cell therapy: Elizabeth Weber, who serves as a logistical nurse navigator, and Heath...

Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL Recorded on September 3, 2019 Join Dr. Miller as he speaks with Dr. Frederick Locke from Moffitt Cancer Center in Tampa, FL on the future of CAR T-cell therapy. In this episode, Dr. Locke discusses new indications for treatment, including off-the-shelf CAR T-cells, earlier lines of therapy, allogeneic treatment options, the necessity for pre...

Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center and Gunjan Shah, MD, Memorial Sloan Kettering Cancer Center Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019 Tune in as Dr. Sergio Giralt and Dr. Gunjan Shah, hematologist-oncologists at Memorial Sloan Kettering Cancer Center in New York, discuss adverse effects and financial toxicities...

Dennis Cooper, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019 What is CAR T-cell therapy? Listen in as Dr. Dennis Cooper, Professor of Medicine and Chief of the Bone Marrow Transplant Service at Rutgers Cancer Institute of New Jersey, reviews the principles of CAR T-cell therapy,...

Susan O’Brien, MD, University of California, Irvine, CA Recorded on April 5, 2019 In this episode, Dr. Ken Miller speaks with Dr. Susan O’Brien, a hematologist/oncologist at the University of California, Irvine about the standard of care for patients with chronic lymphocytic leukemia. Dr. O’Brien describes the biology of CLL, the complexities of available treatment options, how to choose a d...

Amy Burd, PhD, Vice President of Research and Strategy, and Alissa Gentile, MSN, RN, Director of the Clinical Trial Support Center at The Leukemia & Lymphoma Society Recorded on May 10, 2019 Join Dr. Ken Miller as he speaks with Dr. Amy Burd, Vice President of Research and Strategy, and Alissa Gentile, Director of the Clinical Trial Support Center at The Leukemia & Lymphoma Society about L...

Brad Zebrack, PhD, MSW, The University of Michigan School of Social Work, Ann Arbor, MI Recorded on March 5, 2019 Dr. Brad Zebrack, Professor of Social Work at The University of Michigan School of Social Work in Ann Arbor, MI, shares his insights into the unique challenges faced by young adult cancer survivors. Dr. Zebrack discusses young adult survivors’ struggle for independence, challenges with...

Richard, MDS survivor since 2016, Nancy, Caregiver, and Vu Duong, MD, University of Maryland School of Medicine, Baltimore, MD Recorded on February 26, 2019 In this episode, Dr. Miller speaks with Richard, an MDS survivor, his wife Nancy and treating physician, Dr. Vu Duong, an Assistant Professor of Medicine at the University of Maryland School of Medicine in Baltimore, MD as they discuss their u...

Raymond Comenzo, MD, Tufts Medical Center, Boston, MA Recorded on December 14, 2018 In this episode, Dr. Raymond Comenzo, a hematologist/oncologist at Tufts University School of Medicine in Boston, MA, breaks down the biology of AL amyloidosis, how it affects organs throughout the body, and how it is being treated in the hospital today. AL amyloidosis is a rare disorder in which there is a buildup...

Lewis Silverman, MD, Boston Children’s Hospital, Boston, MA Recorded on February 7, 2019 Learn more as Dr. Lewis Silverman, a pediatric hematologist-oncologist at Boston Children’s Hospital in Boston, MA, discusses medical advances in pediatric hematologic malignancies, the role of immunotherapy, late relapse, the role of checkpoint inhibitors, and improving the quality of cure with a focus...

Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on December 28, 2018 The conversation continues with Dr. Richardson in Part II of a two part episode on myeloma by describing the phases of treatment: induction remission therapy, consolidation and maintenance. Dr. Richardson provides an in-depth view of real-world issues patients experience, describes combination drug therapie...

Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on December 28, 2018 On Part I of a two part episode, Dr. Ken Miller talks with Dr. Paul Richardson, a hematologist/oncologist at Dana-Farber Cancer Center in Boston, MA, as he describes his journey as a clinical investigator and how that journey shaped his perspective when treating patients. Dr. Richardson discusses the biolog...

Alice Mims, MD, MSCR, The James, The Ohio State University Comprehensive Cancer Center, Columbus, OH Recorded on January 10, 2019 For many decades, treatment for AML remained stagnant. In recent years, new options have emerged. Join Dr. Ken Miller as he questions Dr. Alice Mims of The Ohio State University Comprehensive Cancer Center in Columbus, Ohio about these treatment updates. Dr. Mims also d...

Naveen Pemmaraju, MD, MD Anderson Cancer Center, Houston, TX Recorded on December 11, 2018 Join Drs. Naveen Pemmaraju and Ken Miller as they discuss the diagnosis, treatment, and management of blastic plasmacytoid dendritic cell neoplasm (BPDCN), an often misdiagnosed and highly aggressive hematologic malignancy. Dr. Pemmaraju is a hematologist/oncologist at MD Anderson Cancer Center in Houston, T...